Reply to Anthony et al., "protecting Pyrazinamide, a priority for improving outcomes in multidrug-resistant tuberculosis treatment

M. O. Fofana, D. W. Dowdy

Research output: Contribution to journalLetter

Original languageEnglish (US)
Article numbere00427-17
JournalAntimicrobial agents and chemotherapy
Volume61
Issue number6
DOIs
StatePublished - Jun 2017

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this